Our experienced QA team ensures rigorous quality checks at every stage of production, guaranteeing the highest standards of performance and reliability.
Agile Bioscience is an India-based organization headquartered in Ahmedabad, Gujarat, committed to empowering scientific advancement through specialized bio-characterization services. Our mission is to support the development of biologics, biosimilars, and complex therapeutics by delivering high-quality, regulatory-aligned analytical data.
With a team of experienced scientists and cutting-edge laboratory infrastructure, we offer a comprehensive suite of analytical techniques tailored to the needs of the pharmaceutical, biotechnology, and academic sectors. From structural characterization and impurity profiling to method development and validation, our services are designed to meet the evolving demands of global healthcare innovation.
Our strength lies in our deep scientific expertise and a collaborative approach. Through a strong network of technically skilled professionals, we enable clients—both local and international—to navigate challenges related to product quality, safety, and regulatory compliance with confidence and precision.
At Agile Bioscience, science drives solutions.
Our Mission
Our Expertise
At Agile Bioscience, we specialize in advanced analytical solutions that provide deep insights into protein and peptide structure, composition, and quality. Our core expertise includes:
- Amino Acid Analysis: Accurate quantification and profiling of amino acid composition to support protein identity, purity, and yield assessments.
- Glycosylation Profiling: Comprehensive characterization of glycan structures attached to proteins, essential for understanding biological activity, efficacy, and immunogenicity.
- Peptide Mapping: Detailed mapping and sequencing of peptides using LC-MS/MS to confirm protein primary structure, detect modifications, and ensure batch-to-batch consistency.
- Structural Characterization: Application of high-resolution mass spectrometry, chromatography, spectroscopy, and other advanced techniques to assess protein folding, higher-order structure, aggregation, and stability.
Our methodologies are designed to meet stringent regulatory standards, supporting product development across discovery, preclinical, and commercial stages.
Our Commitment
At Agile Bioscience, our commitment goes beyond delivering data — we strive to be a trusted scientific partner in your journey from discovery to development. We ensure excellence through:
- Unmatched Expertise: Our team of highly skilled scientists brings deep domain knowledge and hands-on experience in protein and peptide analysis, ensuring scientifically robust outcomes.
- State-of-the-Art Instrumentation: We employ cutting-edge analytical platforms—ranging from high-resolution mass spectrometry to advanced chromatographic and biophysical tools—to generate high-quality, reproducible data.
- Collaborative Approach We believe in close collaboration with our clients, aligning our analytical strategies with their scientific goals to provide customized, actionable insights.
- Quality Assurance: Our operations are underpinned by stringent quality control systems and best laboratory practices to ensure accuracy, consistency, and regulatory readiness.
Our Mission
To redefine excellence in protein and peptide analysis by delivering high-impact, regulatory-ready data that accelerates the development of next-generation biotherapeutics — ultimately transforming human health on a global scale.
Our Vision
To be the most trusted and innovative analytical partner in the biopharmaceutical ecosystem, driving scientific breakthroughs and shaping the future of biologics through unmatched expertise, cutting-edge technology, and a commitment to quality without compromise.
Diverse Molecule Profiling Capabilities
At Agile Bioscience, we have successfully supported the analytical development and characterization of a wide range of biologics, biosimilars, and complex molecules. Our experience includes:
- Monoclonal Antibodies (mAbs): Analytical characterization of IgG1, IgG2, IgG4 antibodies including biosimilars of Trastuzumab, Adalimumab, Bevacizumab, Rituximab, and Pembrolizumab.
- Peptides & Oligopeptides: Sequence confirmation, purity, aggregation, and modification profiling of therapeutic peptides such as Semaglutide, Liraglutide, Linaclotide, Teduglutide, and Tirzepatide.
- Fusion Proteins & ADCs: In-depth analysis of fusion proteins like Etanercept and ADC biosimilars targeting Trastuzumab Emtansine (T-DM1), including DAR (Drug-to-Antibody Ratio) and payload profiling.
- Glycoproteins & Cytokines: Characterization of Erythropoietin (EPO), Granulocyte Colony Stimulating Factor (G-CSF, Filgrastim/Pegfilgrastim), and Interferons, focusing on glycosylation and potency.
- Vaccines & Recombinant Proteins: Support for protein-based vaccines and antigens including Tetanus Toxoid, Pertussis Antigens, Recombinant Hepatitis B surface antigen, and rHSA (recombinant human serum albumin).
- PEGylated Proteins: Characterization of Pegfilgrastim, PEG-EPO, and custom PEGylated biologics for conjugation efficiency, PEG size distribution, and stability.
With experience across innovator molecules and global biosimilar development programs, we deliver data that drives confident regulatory decisions.
We invite you to partner with Agile BioScience for your protein analysis needs. Contact us today to discuss your specific requirements.
